Carboplatin based induction chemotherapy for nonorgan confined bladder cancer - A reasonable alternative for cisplatin unfit patients?

Journal of Urology

Volumn 188, Issue 4, 2012, Pages 1108-1114

  Mertens, Laura S ^a   Meijer, Richard P ^a   Kerst, J Martijn ^a   Bergman, Andries M ^a   Van Tinteren, Harm ^a   Van Rhijn, Bas W G ^a   Horenblas, Simon ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

carboplatin; cisplatin; urinary bladder; urinary bladder neoplasms; urothelium

Indexed keywords

CARBOPLATIN; CISPLATIN; GEMCITABINE;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER STAGING; CLINICAL ASSESSMENT TOOL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CYSTECTOMY; CYSTOSCOPY; DISEASE SPECIFIC SURVIVAL; DRUG WITHDRAWAL; FEMALE; HUMAN; INDUCTION CHEMOTHERAPY; KAPLAN MEIER METHOD; KIDNEY FAILURE; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALAISE; MALE; MULTIPLE CYCLE TREATMENT; MULTIVARIATE ANALYSIS; NEPHROTOXICITY; NONORGAN CONFINED UROTHELIAL CARCINOMA; OTOTOXICITY; PELVIS LYMPH NODE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RESPONSE EVALUATION CRITERIA IN SOLID TUMORS; TRANSITIONAL CELL CARCINOMA; TREATMENT RESPONSE;

EID: 84866098565     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2012.06.018     Document Type: Article

References (22)

1. H.B. Grossman, R.B. Natale, C.M. Tangen Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer N Engl J Med 349 2003 859
2. P.U. Malmström, E. Rintala, R. Wahlqvist Five-year followup of a prospective trial of radical cystectomy and neoadjuvant chemotherapy: Nordic Cystectomy Trial I The Nordic Cooperative Bladder Cancer Study Group J Urol 155 1996 1903
3. Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial International Collaboration of Trialists Lancet 354 1999 533
4. Advanced Bladder Cancer (ABC) Meta-analysis Collaboration Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration Eur Urol 48 2005 202
5. G. Griffiths, R. Hall, R. Sylvester International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial J Clin Oncol 29 2011 2171
6. M.D. Galsky, N.M. Hahn, J. Rosenberg A consensus definition of patients with metastatic urothelial carcinoma who are unfit for cisplatin-based chemotherapy Lancet Oncol 12 2011 211
7. M.D. Galsky, N.M. Hahn, J. Rosenberg Treatment of patients with metastatic urothelial cancer "unfit" for cisplatin-based chemotherapy J Clin Oncol 29 2011 2432
8. A. Dash, M.D. Galsky, A.J. Vickers Impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in patients with urothelial carcinoma of the bladder Cancer 107 2006 506
9. L.H. Sobin, M.K. Gospodarowicz, C. Wittekind TNM Classification of Malignant Tumours 7th ed. 2009 Wiley-Blackwell Oxford
10. J.A. Nieuwenhuijzen, A. Bex, W. Meinhardt Neoadjuvant methotrexate, vinblastine, doxorubicin and cisplatin for histologically proven lymph node positive bladder cancer J Urol 174 2005 80
11. E.A. Eisenhauer, P. Therasse, J. Bogaerts New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) Eur J Cancer 45 2009 228
12. D.F. Bajorin, P.M. Dodd, M. Mazumdar Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy J Clin Oncol 17 1999 3173
13. R. Millikan, C. Dinney, D. Swanson Integrated therapy for locally advanced bladder cancer: final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VAC J Clin Oncol 19 2001 4005
14. D.C. Smith, N.J. Mackler, R.L. Dunn Phase II trial of paclitaxel, carboplatin and gemcitabine in patients with locally advanced carcinoma of the bladder J Urol 180 2008 2384
15. M. Hussain, U. Vaishampayan, W. Du Combination paclitaxel, carboplatin, and gemcitabine is an active treatment for advanced urothelial cancer J Clin Oncol 19 2001 2527
16. L. Dogliotti, G. Carteni, S. Siena Gemcitabine plus cisplatin versus gemcitabine plus carboplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium: results of a randomized phase 2 trial Eur Urol 52 2007 134
17. J. Bellmunt, A. Ribas, J. Albanell M-CAVI, a neoadjuvant carboplatin-based regimen for the treatment of T2-4N0M0 carcinoma of the bladder Am J Clin Oncol 19 1996 344
18. M. De Santis, J. Bellmunt, G. Mead Randomized phase II/III trial assessing gemcitabine/ carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer "unfit" for cisplatin-based chemotherapy: phase II - results of EORTC study 30986 J Clin Oncol 27 2009 5634
19. S. Culine, A. Flechon, A. Guillot Gemcitabine or gemcitabine plus oxaliplatin in the first-line treatment of patients with advanced transitional cell carcinoma of the urothelium unfit for cisplatin-based chemotherapy: a randomized phase 2 study of the French Genitourinary Tumor Group (GETUG V01) Eur Urol 60 2011 1251
20. M. Nogue-Aliguer, J. Carles, A. Arrivi Gemcitabine and carboplatin in advanced transitional cell carcinoma of the urinary tract: an alternative therapy Cancer 97 2003 2180
21. J. Bellmunt, R. de Wit, J. Albanell A feasibility study of carboplatin with fixed dose of gemcitabine in "unfit" patients with advanced bladder cancer Eur J Cancer 37 2001 2212
22. C. Shannon, C. Crombie, A. Brooks Carboplatin and gemcitabine in metastatic transitional cell carcinoma of the urothelium: effective treatment of patients with poor prognostic features Ann Oncol 12 2001 947